We are live on
!
Find out more
PSC
Prentiss Smith & Co Portfolio holdings
AUM
$172M
1-Year Est. Return
21.18%
This Fund
S&P 500
This Quarter
Est. Return
+7.05%
1 Year Est. Return
+21.18%
3 Year Est. Return
+55.24%
5 Year Est. Return
+52.07%
10 Year Est. Return
+229.25%
AUM
$175M
AUM Growth
+$10.3M
(+6.2%)
Cap. Flow
-$618K
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
50.43%
Holding
283
New
14
Increased
15
Reduced
52
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street
STT
|
+$5.01M |
| 2 |
FedEx
FDX
|
+$4.98M |
| 3 |
Gilead Sciences
GILD
|
+$3.35M |
| 4 |
Ameriprise Financial
AMP
|
+$1.07M |
| 5 |
Agilent Technologies
A
|
+$605K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$5.74M |
| 2 |
Unilever
UL
|
+$2.41M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.71M |
| 4 |
Chevron
CVX
|
+$717K |
| 5 |
JPMorgan Chase
JPM
|
+$597K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.27% |
| 2 | Technology | 14.47% |
| 3 | Industrials | 13.67% |
| 4 | Communication Services | 11.16% |
| 5 | Financials | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Novartis
NVS
$285B
| $10.5M | 5.99% |
136,042
-1,532
| -1% | -$113K |
|
2
Alphabet (Google) Class C
GOOG
$4.29T
| $9.99M | 5.7% |
167,440
-2,840
| -2% | -$170K |
|
3
Johnson & Johnson
JNJ
$599B
| $9.84M | 5.61% |
71,242
+2,440
| +4% | +$324K |
|
4
Arista Networks
ANET
$213B
| $9.68M | 5.52% |
582,752
-4,560
| -0.8% | -$77.6K |
|
|
WBA
5
DELISTED
Walgreens Boots Alliance
WBA
| $8.62M | 4.91% |
118,225
-2,688
| -2% | -$183K |
|
6
Abbott
ABT
$177B
| $8.56M | 4.88% |
116,642
-957
| -0.8% | -$62.8K |
|
7
US Bancorp
USB
$98.4B
| $8.36M | 4.76% |
158,203
-1,635
| -1% | -$86.6K |
|
|
CERN
8
DELISTED
Cerner Corp
CERN
| $8.29M | 4.73% |
128,728
-1,355
| -1% | -$86.2K |
|
9
Vodafone
VOD
$35.5B
| $7.37M | 4.2% |
339,750
-2,694
| -0.8% | -$62.6K |
|
10
Medtronic
MDT
$107B
| $7.26M | 4.14% |
73,851
-701
| -0.9% | -$64.8K |
|
11
United Parcel Service
UPS
$96.2B
| $7.18M | 4.09% |
61,483
-469
| -0.8% | -$55.2K |
|
|
ORBK
12
DELISTED
Orbotech Ltd
ORBK
| $6.52M | 3.72% |
109,714
-895
| -0.8% | -$56K |
|
|
13
FedEx
FDX
$73.1B
| $5.19M | 2.96% |
21,551
+20,559
| +2,072% | +$4.98M |
|
|
14
State Street
STT
$50.2B
| $4.98M | 2.84% |
59,488
+57,051
| +2,341% | +$5.01M |
|
15
Regal Rexnord
RRX
$13.7B
| $4.65M | 2.65% |
56,412
-514
| -0.9% | -$42.7K |
|
16
Cisco
CSCO
$436B
| $4.62M | 2.63% |
94,964
-1,757
| -2% | -$79K |
|
|
17
Unilever
UL
$133B
| $4.59M | 2.61% |
74,154
-38,265
| -34% | -$2.41M |
|
18
Lindsay Corp
LNN
$1.15B
| $4.53M | 2.58% |
45,234
-265
| -0.6% | -$24.9K |
|
19
Hain Celestial
HAIN
$47.8M
| $4.21M | 2.4% |
155,114
-3,266
| -2% | -$93.2K |
|
|
20
Gilead Sciences
GILD
$165B
| $3.65M | 2.08% |
47,285
+44,372
| +1,523% | +$3.35M |
|
|
21
Regeneron Pharmaceuticals
REGN
$70.5B
| $2.78M | 1.58% |
6,874
-4,494
| -40% | -$1.71M |
|
22
Procter & Gamble
PG
$347B
| $2.75M | 1.57% |
33,042
-827
| -2% | -$67.6K |
|
23
ExxonMobil
XOM
$615B
| $2.12M | 1.21% |
24,952
-5,439
| -18% | -$445K |
|
24
Berkshire Hathaway Class B
BRK.B
$1.06T
| $1.59M | 0.9% |
7,411
| – | – |
|
25
Microsoft
MSFT
$2.99T
| $1.32M | 0.75% |
11,543
| – | – |
|
Similar funds
CRFG
TA
WCM
BIA
GWCM
PWM
SPF
AIG
Prentiss Smith & Co's Q3 2018 Portfolio in Review
As of Q3 2018, Prentiss Smith & Co held 283 positions worth $175M, up 6.2% from $165M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Prentiss Smith & Co's Q3 2018 filing shows 14 new, 15 increased, 52 reduced and 24 closed positions. Its largest new stake was abrdn Physical Gold Shares ETF: 9,300 shares worth $107K. The largest sale was Oracle, an estimated $5.74M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.
- Prentiss Smith & Co's largest Q3 2018 buy was abrdn Physical Gold Shares ETF: 9,300 shares worth $107K.
- Prentiss Smith & Co added most to State Street in Q3 2018, an estimated $5.01M increase.
- Prentiss Smith & Co's biggest Q3 2018 reduction was Oracle, cutting an estimated $5.74M.
- Prentiss Smith & Co fully exited Foundation Medicine, Inc. in Q3 2018, selling an estimated $490K.
- Prentiss Smith & Co's ten largest holdings make up 50% of its $175M portfolio in Q3 2018.
- Prentiss Smith & Co opened 14 new positions and closed 24 in Q3 2018.
- Prentiss Smith & Co's portfolio value rose 6.2% quarter-over-quarter to $175M.
Based on Prentiss Smith & Co's 13F filing for Q3 2018, filed 23 Oct 2018.